BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19366693)

  • 1. Specific and slow inhibition of the kir2.1 K+ channel by gambogic acid.
    Zaks-Makhina E; Li H; Grishin A; Salvador-Recatala V; Levitan ES
    J Biol Chem; 2009 Jun; 284(23):15432-8. PubMed ID: 19366693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP
    Scherer D; Schworm B; Seyler C; Xynogalos P; Scholz EP; Thomas D; Katus HA; Zitron E
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jul; 390(7):701-710. PubMed ID: 28365825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol sensitivity and lipid raft targeting of Kir2.1 channels.
    Romanenko VG; Fang Y; Byfield F; Travis AJ; Vandenberg CA; Rothblat GH; Levitan I
    Biophys J; 2004 Dec; 87(6):3850-61. PubMed ID: 15465867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen inhibits inward rectifier K+ 2.x family of inward rectifier channels by interfering with phosphatidylinositol 4,5-bisphosphate-channel interactions.
    Ponce-Balbuena D; López-Izquierdo A; Ferrer T; Rodríguez-Menchaca AA; Aréchiga-Figueroa IA; Sánchez-Chapula JA
    J Pharmacol Exp Ther; 2009 Nov; 331(2):563-73. PubMed ID: 19654266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of an inward rectifier channel (IKir) found in avian vestibular hair cells: cloning and expression of pKir2.1.
    Correia MJ; Wood TG; Prusak D; Weng T; Rennie KJ; Wang HQ
    Physiol Genomics; 2004 Oct; 19(2):155-69. PubMed ID: 15316115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct activation of an inwardly rectifying potassium channel by arachidonic acid.
    Liu Y; Liu D; Heath L; Meyers DM; Krafte DS; Wagoner PK; Silvia CP; Yu W; Curran ME
    Mol Pharmacol; 2001 May; 59(5):1061-8. PubMed ID: 11306688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kir2.1 and K2P1 channels reconstitute two levels of resting membrane potential in cardiomyocytes.
    Zuo D; Chen K; Zhou M; Liu Z; Chen H
    J Physiol; 2017 Aug; 595(15):5129-5142. PubMed ID: 28543529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen sulfide inhibits Kir2 and Kir3 channels by decreasing sensitivity to the phospholipid phosphatidylinositol 4,5-bisphosphate (PIP
    Ha J; Xu Y; Kawano T; Hendon T; Baki L; Garai S; Papapetropoulos A; Thakur GA; Plant LD; Logothetis DE
    J Biol Chem; 2018 Mar; 293(10):3546-3561. PubMed ID: 29317494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore.
    Amorós I; Dolz-Gaitón P; Gómez R; Matamoros M; Barana A; de la Fuente MG; Núñez M; Pérez-Hernández M; Moraleda I; Gálvez E; Iriepa I; Tamargo J; Caballero R; Delpón E
    Biochem Pharmacol; 2013 Jul; 86(2):267-78. PubMed ID: 23648307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Select α-arrestins control cell-surface abundance of the mammalian Kir2.1 potassium channel in a yeast model.
    Hager NA; Krasowski CJ; Mackie TD; Kolb AR; Needham PG; Augustine AA; Dempsey A; Szent-Gyorgyi C; Bruchez MP; Bain DJ; Kwiatkowski AV; O'Donnell AF; Brodsky JL
    J Biol Chem; 2018 Jul; 293(28):11006-11021. PubMed ID: 29784874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A difference in inward rectification and polyamine block and permeation between the Kir2.1 and Kir3.1/Kir3.4 K+ channels.
    Makary SM; Claydon TW; Enkvetchakul D; Nichols CG; Boyett MR
    J Physiol; 2005 Nov; 568(Pt 3):749-66. PubMed ID: 16109731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conduction through the inward rectifier potassium channel, Kir2.1, is increased by negatively charged extracellular residues.
    D'Avanzo N; Cho HC; Tolokh I; Pekhletski R; Tolokh I; Gray C; Goldman S; Backx PH
    J Gen Physiol; 2005 May; 125(5):493-503. PubMed ID: 15824191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inward rectifier potassium (Kir2.1) channels as end-stage boosters of endothelium-dependent vasodilators.
    Sonkusare SK; Dalsgaard T; Bonev AD; Nelson MT
    J Physiol; 2016 Jun; 594(12):3271-85. PubMed ID: 26840527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of gamma-aminobutyric acid receptor-interacting factor 1 (TRAK2) as a trafficking factor for the K+ channel Kir2.1.
    Grishin A; Li H; Levitan ES; Zaks-Makhina E
    J Biol Chem; 2006 Oct; 281(40):30104-11. PubMed ID: 16895905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric parietal cell secretory membrane contains PKA- and acid-activated Kir2.1 K+ channels.
    Malinowska DH; Sherry AM; Tewari KP; Cuppoletti J
    Am J Physiol Cell Physiol; 2004 Mar; 286(3):C495-506. PubMed ID: 14602583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action potential clamp and chloroquine sensitivity of mutant Kir2.1 channels responsible for variant 3 short QT syndrome.
    El Harchi A; McPate MJ; Zhang Yh; Zhang H; Hancox JC
    J Mol Cell Cardiol; 2009 Nov; 47(5):743-7. PubMed ID: 19285083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute suppression of inwardly rectifying Kir2.1 channels by direct tyrosine kinase phosphorylation.
    Wischmeyer E; Döring F; Karschin A
    J Biol Chem; 1998 Dec; 273(51):34063-8. PubMed ID: 9852063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stretch-induced alterations of human Kir2.1 channel currents.
    He Y; Xiao J; Yang Y; Zhou Q; Zhang Z; Pan Q; Liu Y; Chen Y
    Biochem Biophys Res Commun; 2006 Dec; 351(2):462-7. PubMed ID: 17067550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiopental inhibits function of different inward rectifying potassium channel isoforms by a similar mechanism.
    López-Izquierdo A; Ponce-Balbuena D; Ferrer T; Rodríguez-Menchaca AA; Sánchez-Chapula JA
    Eur J Pharmacol; 2010 Jul; 638(1-3):33-41. PubMed ID: 20447386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in the titer of lentiviral vectors expressing potassium channels by current blockade during viral vector production.
    Okada M; Andharia N; Matsuda H
    BMC Neurosci; 2015 May; 16():30. PubMed ID: 25940378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.